Prognostic value of FUS immunoexpression for Gleason patterns and prostatic adenocarcinoma progression.

Background: Risk assessment is important when planning treatment for prostatic adenocarcinoma. Gleason score is a strong predictor of disease progression, despite the possibility of mismatches between biopsy and prostatectomy. In order to increase the accuracy of Gleason scores, several markers have been proposed.